Vistin Pharma ASA Balance Sheet

Financials in millions NOK. Fiscal year is January - December.

Millions NOK. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	6.33	16.42	12.79	26.2	1.44	35.75
Cash & Short-Term Investments	6.33	16.42	12.79	26.2	1.44	35.75
Cash Growth	-50.04%	28.33%	-51.18%	1726.06%	-95.99%	-53.60%
Accounts Receivable	100.16	89.71	44.28	47.02	66.16	40.25
Other Receivables	28.12	15.26	7.7	12.56	5.01	2.85
Receivables	128.28	104.97	51.98	59.59	71.17	43.09
Inventory	82.93	82.13	76.67	80.17	83.45	42.91
Prepaid Expenses	-	-	1.75	2.81	3.14	16.09
Other Current Assets	-0	0	-	-	-	-
Total Current Assets	217.54	203.52	143.19	168.77	159.18	137.83
Property, Plant & Equipment	223.87	223.75	229.6	219.98	219.43	167.46
Long-Term Deferred Tax Assets	-	-	-	14.64	28.6	27.86
Other Long-Term Assets	12.15	12.15	12.16	-	-	0
Total Assets	453.56	439.43	384.95	403.4	407.21	333.15
Accounts Payable	25.41	30.24	13.05	18.92	25.91	20.81
Accrued Expenses	-	-	15.82	16.59	14.67	16.58
Short-Term Debt	-	-	-	-	45.14	-
Current Portion of Leases	-	0.88	-	-	1.07	0.88
Other Current Liabilities	48.11	47.87	35.1	33.96	30.78	2.78
Total Current Liabilities	73.52	78.99	63.97	69.47	117.57	41.04
Long-Term Leases	0.5	0.62	1.33	-	2.96	0.51
Pension & Post-Retirement Benefits	6.31	6.42	6.6	8.86	13.2	15.83
Long-Term Deferred Tax Liabilities	22.93	24.59	3.52	-	-	-
Other Long-Term Liabilities	-0	-	0	2.29	-0	0
Total Liabilities	103.25	110.61	75.42	80.63	133.73	57.38
Common Stock	44.35	44.35	44.35	44.35	44.35	44.35
Additional Paid-In Capital	73.87	73.87	129.3	206.89	206.89	206.89
Retained Earnings	232.09	210.61	135.89	71.54	22.26	24.54
Comprehensive Income & Other	0	-	-	-	-	-
Shareholders' Equity	350.31	328.82	309.53	322.77	273.49	275.77
Total Liabilities & Equity	453.56	439.43	384.95	403.4	407.21	333.15
Total Debt	0.5	1.5	1.33	-	49.17	1.39
Net Cash (Debt)	5.83	14.92	11.47	26.2	-47.73	34.36
Net Cash Growth	-45.38%	30.09%	-56.24%	-	-	-55.40%
Net Cash Per Share	0.13	0.34	0.26	0.59	-1.08	0.77
Filing Date Shares Outstanding	44.44	44.34	44.34	44.34	44.34	44.34
Total Common Shares Outstanding	44.44	44.34	44.34	44.34	44.34	44.34
Working Capital	144.02	124.54	79.22	99.3	41.61	96.8
Book Value Per Share	7.88	7.42	6.98	7.28	6.17	6.22
Tangible Book Value	350.31	328.82	309.53	322.77	273.49	275.77
Tangible Book Value Per Share	7.88	7.42	6.98	7.28	6.17	6.22
Machinery	-	-	268.64	263.53	253.37	-
Construction In Progress	-	-	39.09	17.91	10.24	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.